Liquid amnion transplant product
AssigneeVivex Biologics Group, Inc.
InventorsShabnam Namin, Gaëtan Jean-Robert Delcroix
Life of this patent
Estimating the term…
Loading patent…
AssigneeVivex Biologics Group, Inc.
InventorsShabnam Namin, Gaëtan Jean-Robert Delcroix
Estimating the term…
A transplant product made from human amniotic fluid has a supernatant from filtered and centrifuged amniotic fluid, the amniotic fluid when recovered aseptically having a clear, translucent to slightly pink or tan color. The supernatant had been taken from the amniotic fluid which had been passed through a 170 to 260 micron blood filter, then centrifuged for 5 minutes or more at 400 g and thereafter the supernatant was separated from a pellet of debris, leaving the biochemical properties intact, wherein the supernatant is cryofrozen in sized cryovials having 0.25 to 2.0 ml of the supernatant at a temperature of −65 degrees or less prior to use and the transplant products method of use. The transplant product contains cellular material, cell fragments, proteins and growth factors maintaining the biochemical properties and is non-immunogenic while having particles up to 170 microns being passable through a 30 gauge syringe for injection.
A liquid amnion transplant product comprising a supernatant from filtered and centrifuged amniotic fluid:
A method for producing a transplant product, comprising the steps of:
Dependencies are inferred from the claim text.